US device industry advocates standards-based regulatory system
This article was originally published in Clinica
A draft legislative package to reform the US FDA was distributed by US medical device trade groups last week to Congressional committees. The Health Industry Manufacturers Association (HIMA), the National Electrical Manufacturers Association (NEMA) and the National Medical Device Coalition (NMDC) reached consensus on FDA reform after several months of discussion.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.